← Back to Search
Novel Factors In The Pathogenesis Of Psoriasis And Potential Drug Candidates Are Found With Systems Biology Approach
M. Manczinger, L. Kemény
Published 2013 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Psoriasis is a multifactorial inflammatory skin disease characterized by increased proliferation of keratinocytes, activation of immune cells and susceptibility to metabolic syndrome. Systems biology approach makes it possible to reveal novel important factors in the pathogenesis of the disease. Protein-protein, protein-DNA, merged (containing both protein-protein and protein-DNA interactions) and chemical-protein interaction networks were constructed consisting of differentially expressed genes (DEG) between lesional and non-lesional skin samples of psoriatic patients and/or the encoded proteins. DEGs were determined by microarray meta-analysis using MetaOMICS package. We used STRING for protein-protein, CisRED for protein-DNA and STITCH for chemical-protein interaction network construction. General network-, cluster- and motif-analysis were carried out in each network. Many DEG-coded proteins (CCNA2, FYN, PIK3R1, CTGF, F3) and transcription factors (AR, TFDP1, MEF2A, MECOM) were identified as central nodes, suggesting their potential role in psoriasis pathogenesis. CCNA2, TFDP1 and MECOM might play role in the hyperproliferation of keratinocytes, whereas FYN may be involved in the disturbed immunity in psoriasis. AR can be an important link between inflammation and insulin resistance, while MEF2A has role in insulin signaling. A controller sub-network was constructed from interlinked positive feedback loops that with the capability to maintain psoriatic lesional phenotype. Analysis of chemical-protein interaction networks detected 34 drugs with previously confirmed disease-modifying effects, 23 drugs with some experimental evidences, and 21 drugs with case reports suggesting their positive or negative effects. In addition, 99 unpublished drug candidates were also found, that might serve future treatments for psoriasis.
This paper references
Network motifs: structure does not determine function
P. Ingram (2005)
Pathogenesis and clinical features of psoriasis
C. Griffiths (2007)
Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs
L. Johnson-Huang (2012)
Proximity of intracellular regulatory networks to monotone systems.
Avi Ma’ayan (2008)
Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice.
Jiann-jyh Lai (2012)
Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
B. Davidovici (2010)
Fyn Deficiency Promotes a Preferential Increase in Subcutaneous Adipose Tissue Mass and Decreased Visceral Adipose Tissue Inflammation
Ting-Wen A. Lee (2013)
arrayQualityMetrics—a bioconductor package for quality assessment of microarray data
A. Kauffmann (2009)
Absence of a Human DnaJ Protein hTid-1S Correlates with Aberrant Actin Cytoskeleton Organization in Lesional Psoriatic Skin*
Ji Hye Choi (2012)
Meta-Analysis Derived (MAD) Transcriptome of Psoriasis Defines the “Core” Pathogenesis of Disease
S. Tian (2012)
Exacerbation and induction of psoriasis by angiotensin-converting enzyme inhibitors.
K. Ikai (1995)
Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.
A. Armstrong (2013)
Onset of psoriasis during therapy with fluoxetine.
Lynnette Tan Pei Lin (2010)
Investigation for the leptin 1 and LEP G2548A gene polymorphism in psoriasis.
N. Senturk (2008)
Atorvastatin for the Treatment of Plaque‐Type Psoriasis
T. Faghihi (2011)
Lithium Regulates Keratinocyte Proliferation Via Glycogen Synthase Kinase 3 and NFAT2 (Nuclear Factor of Activated T Cells 2)
P. Hampton (2012)
Nonstandard and off-label therapies for psoriasis.
Caroline P. Halverstam (2008)
NetMatch: a Cytoscape plugin for searching biological networks
A. Ferro (2007)
PPARδ Enhances Keratinocyte Proliferation in Psoriasis and Induces Heparin-Binding EGF-Like Growth Factor
M. Romanowska (2008)
Psoriasis during therapy with olanzapine.
A. Latini (2003)
Interlinked Fast and Slow Positive Feedback Loops Drive Reliable Cell Decisions
Onn Brandman (2005)
Efficacy of simvastatin in plaque psoriasis: A pilot study.
I. Shirinsky (2007)
The role of salicylic acid in the treatment of psoriasis
M. Lebwohl (1999)
Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial.
S. Kurd (2008)
Type I Interferon: Potential Therapeutic Target for Psoriasis?
Y. Yao (2008)
IFN-gamma and TNF-alpha synergize to inhibit CTGF expression in human lung endothelial cells
R Laug (2012)
An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection
Xingbin Wang (2012)
Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis
A. Malhotra (2012)
A novel function for Cyclin A2: Control of cell invasion via RhoA signaling
N. Arsic (2012)
STAT1 expression and activation is increased in lesional psoriatic skin
A. Hald (2013)
Complete resolution of psoriasis in a patient treated with stealth liposomal doxorubicin and carboplatin for ovarian cancer
C. Pisano (2004)
Cytoscape 2.8: new features for data integration and network visualization
Michael E. Smoot (2011)
Emergence of scaling in random networks
MetaQC: objective quality control and inclusion/exclusion criteria for genomic meta-analysis
D. D. Kang (2012)
STITCH 3: zooming in on protein–chemical interactions
M. Kuhn (2012)
Psoriasis disappearance after the first phase of an oncologic treatment: a serendipity case report.
R. Cagiano (2008)
Rottlerin: bases for a possible usage in psoriasis.
E. Maioli (2010)
Treatment of psoriasis with daunorubicin and cytarabine.
D. Kohn (1980)
Br J Dermatol
Integration of biological networks and gene expression data using Cytoscape
M. Cline (2007)
Psoriatic keratinocytes show reduced IRF‐1 and STAT‐1α activation in response to γ‐IFN
M. Jackson (1999)
Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases
B. Beutler (2009)
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
Hung-Yun Lin (2008)
The IFN-γ–Dependent Suppressor of Cytokine Signaling 1 Promoter Activity Is Positively Regulated by IFN Regulatory Factor-1 and Sp1 but Repressed by Growth Factor Independence-1b and Krüppel-Like Factor-4, and It Is Dysregulated in Psoriatic Keratinocytes
S. Madonna (2010)
Robust and Powerful Tests for Rare Variants Using Fisher's Method to Combine Evidence of Association From Two or More Complementary Tests
A. Derkach (2013)
The dark side of regulatory T cells in psoriasis.
D. C. Soler (2011)
Testosterone serum levels in male psoriatics
W. Schwarz (2004)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian (2005)
Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.
C. Ellis (2000)
Network analysis: methodological foundations. Berlin; New York: Springer. xii, 471 p. p. Network Analysis in Psoriasis PLOS ONE | www.plosone.org 13 November
U Brandes (2005)
BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks
Steven Maere (2005)
Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor.
Markella-Pagona Zorzou (2004)
Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle.
A. Farkas (2012)
Remission of psoriasis vulgaris from the use of nerve-blocking agents.
H. Perlman (1972)
Stat3 as a therapeutic target for the treatment of psoriasis : a clinical feasibility study with STA-21, a Stat3 inhibitor
三好 研 (2010)
Mammalian target of rapamycin and its downstream signalling components are activated in psoriatic skin
C. Buerger (2013)
Protein Expression of TNF-α in Psoriatic Skin Is Regulated at a Posttranscriptional Level by MAPK-Activated Protein Kinase 21
C. Johansen (2006)
Psoriasis Without Neutrophils
D. Paslin (1990)
Current and future management of psoriasis
A. Menter (2007)
A new drug classification for computer systems: the ATC extension code.
G. Miller (1995)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk (2011)
Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.
C. Buerger (2012)
Dystrophic Psoriatic Fingernails Treated with 1% 5-Fluorouracil in a Nail Penetration-Enhancing Vehicle: A Double-Blind Study
E. D. de Jong (1999)
Evaluation of the efficacy of topical caffeine in the treatment of psoriasis vulgaris
A. Vali (2005)
A Report on Three Recent Clinical Trials Using Mahonia aquifolium 10% Topical Cream and a Review of the Worldwide Clinical Experience With Mahonia aquifolium for the Treatment of Plaque Psoriasis
W. Gulliver (2005)
Network Analysis in Psoriasis PLOS ONE | www.plosone
cisRED: a database system for genome-scale computational discovery of regulatory elements
G. Robertson (2006)
Efficacy of 2 weeks' application of theophylline ointment in psoriasis vulgaris
E. Papakostantinou (2005)
EMA - A R package for Easy Microarray data analysis
N. Servant (2010)
Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease.
L. Michalik (2007)
BCR‐ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
S. Roy (2012)
Calcium channel blockers intake and psoriasis: a case-control study.
A. Cohen (2001)
Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems
T. Scholzen (1998)
Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.
S. Kippenberger (2001)
PPARdelta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor.
M. Romanowska (2008)
Attenuated Pik3r1 Expression Prevents Insulin Resistance and Adipose Tissue Macrophage Accumulation in Diet-Induced Obese Mice
C. McCurdy (2012)
Exacerbation of psoriasis in a chronic myelogenous leukemia patient treated with imatinib
S. M. Woo (2007)
Hubs in biological interaction networks exhibit low changes in expression in experimental asthma
Xin Lu (2007)
Can nicotine use alleviate symptoms of psoriasis?
J. Staples (2012)
Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment
T. Kim (2011)
Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha.
M. K. Hwang (2009)
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.
Rui Han (2012)
Intralesional therapy for psoriasis
T. Wang (2013)
Interferon-γ-induced increases in intestinal epithelial macromolecular permeability requires the Src kinase Fyn
D. Smyth (2011)
Dual functions of DP1 promote biphasic Wnt‐on and Wnt‐off states during anteroposterior neural patterning
Wan-Tae Kim (2012)
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1
L. van der Fits (2009)
NetMODE: Network Motif Detection without Nauty
X. Li (2012)
Insulin-like growth factor II induces interleukin-6 expression via NFkappaB activation in psoriasis.
Y. Kwon (2000)
NF-κB: an essential transcription factor in psoriasis.
A. Goldminz (2013)
5 – Pathogenesis of disease
J. C. Lee (2004)
Chloroquine stimulates the mitogen-driven lymphocyte proliferation in patients with psoriasis.
R. Schopf (1993)
From genomics to chemical genomics: new developments in KEGG
M. Kanehisa (2006)
JASPAR: an open-access database for eukaryotic transcription factor binding profiles
A. Sandelin (2004)
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
R. Parisi (2013)
NF-kappaB: An essential transcription factor in psoriasis
AM Goldminz (2013)
Power laws, Pareto distributions and Zipf's law
M. Newman (2004)
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes.
C. Sticozzi (2013)
PSORS2 is due to mutations in CARD14.
C. Jordan (2012)
IFN-γ and TNF-α Synergize to Inhibit CTGF Expression in Human Lung Endothelial Cells
Roderich Laug (2012)
2013) mTOR and its downstream signalling components are activated in psoriatic skin
BCRABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
S Roy (2012)
Network Analysis: Methodological Foundations
Chris Arney (2012)
Comparison of multiplex meta analysis techniques for understanding the acute rejection of solid organ transplants
Alexander A. Morgan (2010)
Generalized pustular psoriasis precipitated by diclofenac and indomethacin.
E. Sendagorta (1987)
Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
Y. Brauchli (2008)
Psoriasis induced by losartan therapy: a case report and review of the literature.
G. Lamba (2011)
Arsenic Trioxide, Arsenic Pentoxide, and Arsenic Iodide Inhibit Human Keratinocyte Proliferation through the Induction of Apoptosis
W. Tse (2008)
Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease.
Chen N. Young (2008)
TRANSFAC: a database on transcription factors and their DNA binding sites
E. Wingender (1996)
Complete Resolution of Erythrodermic Psoriasis in an HIV and HCV Patient Unresponsive to Antipsoriatic Treatments after Highly Active Antiretroviral Therapy (Ritonavir, Atazanavir, Emtricitabine, Tenofovir)
A. Chiricozzi (2012)
Comparison study of microarray meta-analysis methods
A. Campain (2010)
The MEF2A Isoform Is Required for Striated Muscle-specific Expression of the Insulin-responsive GLUT4 Glucose Transporter*
S. Mora (2000)
mTOR and its downstream signalling components are activated in psoriatic skin
C Buerger (2013)
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
L. Tsoi (2012)
The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules.
A. Johnston (2005)
Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis
M. Suárez-Fariñas (2012)
Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes.
L. Santamaria (1999)
Rifampicin – A mild immunosuppressive agent for psoriasis
N. Tsankov (2011)
Increased expression of Wnt5a in psoriatic plaques.
J. Reischl (2007)
Detecting overlapping protein complexes in protein-protein interaction networks
Tamás Nepusz (2012)
Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN.
M. Jackson (1999)
Insulin-like Growth Factor II Induces Interleukin-6 Expression via NFκB Activation in Psoriasis
Y. Kwon (2000)
Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin.
J. Gudjonsson (2009)
Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study.
Alison Ehrlich (2004)
Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
M. L. Giustizieri (2001)
Serum levels of transforming growth factor‐β1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs
P. G. Kallimanis (2009)
This paper is referenced by
RNAI-MEDIATED SILENCING OF MATRIX METALLOPROTEINASE 1 IN EPIDERMAL KERATINOCYTES INFLUENCES THE BIOLOGICAL EFFECTS OF INTERLEUKIN 17A
Julia Mogulevtseva (2018)
Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation
Sowjanya Thatikonda (2020)
AN INTEGRATED NETWORK ANALYSIS OF PSORIASIS: A NOVEL APPROACH TO DISEASE PATHOLOGY
Alex Anand (2015)
Investigating the role of epigenetics in the regulation of inflammatory skin disease
K. Wu (2016)
Aplicación de métodos de aprendizaje automático para el estudio de la comorbilidad inversa entre cáncer y trastornos del sistema nervioso central
Kristina Ibáñez Garikano (2015)
Drug-target networks for Tanshinone IIA identified by data mining.
Sibao Chen (2015)
High Throughput Screening of Gene Expression for the Investigation of Multifactorial Dermatological Disorders
M. Máté (2016)
Review—Current Concepts in Inflammatory Skin Diseases Evolved by Transcriptome Analysis: In-Depth Analysis of Atopic Dermatitis and Psoriasis
Julius Schwingen (2020)
A Computational approach for identifying novel micro RNAs from Genome Wide Association Studies of Psoriasis
Harishchander Anandaram (2014)
Impact of Metalloproteinase 1 Deficiency Induced by Specific Small Hairpin RNA on the Physiological Effects of Tumor Necrosis Factor
J. Mogulevtseva (2018)
Graphical algorithm for integration of genetic and biological data: proof of principle using psoriasis as a model
L. Tsoi (2015)
Using Micro- and Macro-Level Network Metrics Unveils Top Communicative Gene Modules in Psoriasis
Reyhaneh Naderi (2020)
Network analysis of Urocortins.
Shao-jun Chen (2016)
COMPUTATIONAL APPROACH FOR IDENTIFYING THERAPEUTIC MICRO RNAs
D. A. Anand (2014)
Therapeutic drug monitoring of biologics in psoriasis
M. M. Liau (2019)
Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin
E. Szlavicz (2017)
What have we learned about non-involved psoriatic skin from large-scale gene expression studies?
E. Szlavicz (2014)
BINDING SITE ANALYSIS OF MICRORNAS TARGET INTERACTION FROM GENOME WIDE ASSOCIATION STUDIES
D. A. Anand (2014)
First glimpse of epigenetic effects on pemphigus foliaceus.
M. Spadoni (2019)
Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1
Thayne Woycinck Kowalski (2020)
Investigations on mRNA maturation disturbancies in the pathogenesis of psoriasis
Szlávicz Eszter (2017)
Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD
S. Yoon (2017)
Synthesis and activity of the salicylic acid ester of bakuchiol in psoriasis‐surrogate keratinocytes and skin substitutes
S. Ma (2017)
Drug Repurposing by Simulating Flow Through Protein–Protein Interaction Networks
M. Manczinger (2018)